baber/WOPTO huggingface dataset:
Patent HR-P20100708-T1 (HR)
Title: Cladding formed by panels having a strip flooring look
Inventor: DUERNBERGER GERHARD
IPC: E04F15/02
Filed: 2010-12-20
Abstract: The invention relates to panels having a decorative surface for forming a flooring, to a method for producing the decors and to a flooring made up of said panels. The invention finally relates to a decorative paper. The aim of the invention is to provide panels that allow to produce an inexpensive flooring having a high-quality appearance and to provide a corresponding method for producing them. For this purpose, the décor surfaces of panels on at least one end each are optically adapted to each other to such a degree that, when the panels are laid, they give a continuous image of the décor at the transition from one laid panel to the adjacent laid panel. The wood décor has a continuous image within the meaning of the invention if the grain of the depicted wood is optically uninterrupted at the transition from one laid panel to the adjacent laid panel, i.e. when there is no offset between the respective depicted grains. The same applies for other decors, for example stone decors. In this case, the images of the stone surface are adapted to each other at the transition from one laid panel to the adjacent laid panel in such a manner that one stone extends from the one panel to the next panel without any noticeable offset of the décor at the common joint of the panels.
Patent HR-P20110359-T1 (HR)
Inventor: BONNERT ROGER
IPC: C07D401/12
Filed: 2011-05-16
Abstract: Spoj formule (I), ili njegova farmaceutski prihvatljiva sol ili solvat, naznačen time da je za liječenje bolesti posredovane s CRTh2: gdje: R1 je NHCOMe; R2 je C1-6alkil ili vodik; iR3 je fenil proizvoljno supstituiran sa kloro, metoksi, metilsulfonom ili etilsulfonom. Patent sadrži još 6 patentnih zahtjeva.
Patent SI-1125894-T1 (SI)
Title: Process and apparatus for the further processing of biological waste
Inventor: BAUER FRIEDRICH ING
IPC: B03B5/28
Filed: 2000-02-18
Abstract: In a process to recycle municipal biological refuse, the refuse is deposited in holding container (3) from which it is progressively transferred by conveyer (7) to a water basin (5) where it is spread out, allowing heavy items to sink. Floating items are moved to a crusher/grinder (22) and are then separated into portions for composting or fermentation. Also claimed is an assembly with a holding container (3) and a water basin (5) in which refuse floats or sinks. A cam-operated separator (11) with separator tool repeatedly dips into and moves the floating refuse through the basin towards an inclined conveyer (9). Heavy items sink and migrate into channels (10) for removal. Floating refuse is raised by the conveyer (9) and deposited onto a separator wheel (23). Other refuse drops into a crusher/grinder (22) from which it is fed to a worm extruder (31). The pressed residues are composted or fermented (29,30)-
Patent SI-1901755-T1 (SI)
Title: New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers
Inventor: VACCARO SUSANNA
IPC: A61K31/00
Filed: 2006-07-05
Abstract: The present invention concerns new compositions containing hyaluronic acid or the derivatives thereof in association with the proteolytic enzyme collagenase (and relative pharmaceutical formulations) for the preparation of a dressing for topical treatment of various kinds of wounds, burns of varying depth, pressure sores, vascular ulcers and diabetic foot ulcers as well as for the treatment of hypertrophic and keloid scars.
Patent SI-2190281-T1 (SI)
Title: Geomat
Inventor: HOLLAND-MORITZ JAN
IPC: A01G13/00
Filed: 2008-08-27
Abstract: The invention relates to a geomat for preventing erosion, for recultivating fallow land and for cultivating plants, said mat being completely biodegradable, cost-effective and simple to produce and fulfilling all ecological requirements. According to the invention, the geomat substantially consists of a continuous strand (1) of untreated sheep's wool, arranged in a serpentine to form the desired width of the mat and held together in a longitudinal direction.
Patent SI-3191511-T1 (SI)
Title: Improved tnf binders
Inventor: BUYSE MARIE-ANGE
IPC: C07K16/00
Filed: 2016-11-14
Abstract: The present invention relates to amino acid sequences, compounds and polypeptides binding to tumor necrosis factor alpha ("TNF" or "TNF-alpha"). In particular, the present invention relates to improved heavy-chain immunoglobulin single variable domains (also referred to herein as "ISV's" or "ISVDs") binding to tumor necrosis factor alpha, as well as to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise such ISVDs, collectively TNF binders. Other aspects, embodiments, features, uses and advantages of the invention will be clear to the skilled person based on the disclosure herein.
Patent TR-200402386-T1 (TR)
Title: Çok katlı kumaş üretim yöntemi ve bu yöntemle elde edilen çok katlı kumaş
Inventor: GOEGUES ARIF MEHMET
IPC: D05C17/00
Filed: 2003-03-21
Abstract: Bu bulus, perde, örtü ve benzeri ev tekstil ürünlerinin üretiminde kullanilan bir veya birden çok kata sahip kumaslarin üretilmesiyle ilgili bir yöntem ve bu yöntem sonucunda elde edilen çok katli kumas ile ilgilidir. Bulus konusu üretim yöntemi, istenen sayida üst kat kumasinin (15) tezgaha (9) arkadan üst üste gerilmesi (102); desenin (19) hatlari üzerinden seyrek dikis (18) yapilarak kumaslarin birbirine sabitlenmesi (103); bu hatlar üzerinde nakis (17) islenmesi (108); bir ya da birden çok sayida üst kat kumasinin (15), desenle belirlenen sayida kapli alandan (20) kesilerek çikarilmasi (110) adimlariyla karakterize edilmektedir.
Patent TR-200500636-T1 (TR)
Title: Cam formüllerin üretimi için önceden tepkimeye uğramış ham madde yığınlarının hazırlanmasında kullanılan yöntem
Inventor: PITA-SZCZESNIEWSKI ANTONIO
IPC: C03C1/02
Filed: 2003-08-29
Abstract: Arzu edilen moleküler formülün tamamlanması için, sıvı evresi oluşturmayan bir reaksiyon sıcaklıkları bulunan ve sabit noktalardan ya da evre diyagramlarının sabit noktalarını bağlayan bir hatta yer alan noktalardan seçilen, silika-sodyum, silika-sodyum-kalsiyum,silika-sodyum-magnezyum, silika-kalsiyum-magnezyum, silika-sodyum-kalsiyum-magnezyum ve bunların karışımlarının moleküler sistemlerini içeren seçilmiş stoikiometrik miktarlarının karıştırılmasını, parçalanmış camların karışıma eklenmesini ve bir sıvı evresi oluşturmayan ve CO2'nin serbest bırakıldığı bir reaksiyon sıcaklığında karışımın kalsinasyonunun yapılmasını içeren, cam formüllerin üretimi için önceden tepkimeye uğramış düşük karbon dioksit içerikli sentetik yığınların hazırlanmasında kullanılan bir yöntem.
Patent TR-200502309-T1 (TR)
Inventor: UZ ATILLA
IPC: A47L15/42
Filed: 2003-12-24
Abstract: This invention relates to a dishwasher (1) comprising a biosensor (7) and a control method which provides an efficient, clean and hygienic washing wherein the main water supply and washing water are microbiologically analyzed in the phases of the program, and the washing water temperature and circulation period are adjusted in each phase.
Patent TR-201806404-T1 (TR)
Title: Köpükleşebilen ateşe dayanıklı kaplama bileşimi.
Inventor: SANG HYUN HAN
IPC: C09K21/12
Filed: 2016-11-10
Abstract: Bu tarifname, bir epoksi reçinesi, bir kürleme maddesi, bir alev geciktirici, bir köpükleme maddesi, bir asit katalizörü ve fiber içeren köpükleşebilen ateşe dayanıklı bir kaplama bileşimi ile ilgilidir. Özellikle, mevcut buluş, alev geciktiricinin ağırlıkça %20 veya daha az trifenil fosfat içerdiği ve 250 ? veya daha yüksek bir piroliz sıcaklığına sahip olduğu, bu sayede gaz toksisitesinin azaltıldığı, köpük tabakasına esneklik kazandırıldığı ve karbonize bir tabakada çatlakların oluşması önlenerek uzun süreli yangına dayanıklılığın arttırıldığı, köpükleşebilen yangına dayanıklı bir kaplama bileşimi ile ilgilidir.
Patent DE-3588096-T2 (DE)
Inventor: YOCUM ROBERT ROGERS
IPC: C12N15/90
Filed: 1985-05-22
Granted: 1996-09-05
Abstract: A DNA sequence comprises a gene that codes for resistance to antibiotic G418 functionally coupled to a yeast promoter sequence or to a synthetic promoter sequence. The DNA sequence may be directly selected for in a yeast cell transformed with the DNA. Vectors containing the DNA sequence and a gene encoding the desired heterologous protein can be used to transform yeast cells so that those cells or their descendants may be used to harvest the desired protein. <IMAGE>
Patent DE-3687189-T2 (DE)
Inventor: ISSHIKI SHONAN LIFE TOWN
IPC: A61K35/74
Filed: 1986-05-30
Granted: 1993-07-01
Abstract: The present invention relates to a novel antibiotic and a microbial process of producing the same. The compound MF 730-N6, which is characterized by the following properties:       melting point:  115 - 119 DEG C rotation as measured immediately after preparation of a solution of the antibiotic:  [ alpha ] @@ = -28.5 DEG  (C = 0.46, chloroform)   solubility: soluble in methanol, ethanol, ethyl acetate and ultraviolet absorption spectrum:   lambda <CHEM>  = 203 nm (60), 280 nm (3)   infrared absorption spectrum: distinct characteristic absorption maxima appearing at wave numbers of 3430, 2960, 1705 and 1635 cm<-><1> by the KBr tablet method, is obtained by cultivating a microorganismus of the genus Kitasatosporia capable of producing the compound MF 730-N6 on a nutrient medium and recovering said compound from the culture by usual methods of solvent extraction and/or chromatography, has both anti-tumor and anti-microbial activities and can, therefore, be used as a medicament.
Patent DE-3688826-T2 (DE)
Inventor: FOSH BRIAN FREDERICK
IPC: G03B27/20
Filed: 1986-02-11
Granted: 1994-02-24
Abstract: A vacuum contact system has a vacuum contact frame including a bi-­layer blanket (1) having top and bottom layers (12, 13) spaced apart by a number of parallel strip members (20) to define a first space (19). A bead (14) is positioned around the outer edges of the top layer (12) to support a glass plate (15) so that a second space (17) is formed. Vacuum connectors (16) communicate with the second space and a further vacuum connector (18) communicates with the first space, all the connectors being connected to a vacuum pump (38). The first and second spaces have the atmosphere therein controlled by electromagnetic valves (39, 40) located in a vacuum circuit with the pump (38).In operation a film master (28) and a presensitised material (27) are located in the second space (17) and the vacuum circuit is arranged to remove air from both the first and second spaces (17, 19) so that the two layers of blanket are drawn together. Ridges (30) formed by the strip members (20) are thus formed in the top layer outer surface (12) and these ridges press the film master and presensitised material against the glass plate. The vacuum circuit is then arranged to vent the space between the two blanket layers to atmosphere so that overall contact of the blanket layer (12) is made against the film master (28) and presensitised material (27) which are thus sandwiched between the blanket layer (1) and the glass plate (15) substantially over the whole area of the film master (28).
Patent DE-3689508-T2 (DE)
Inventor: IENAGA KAZUHARU INST BIO-ACTIV
IPC: A61K31/195
Filed: 1986-10-08
Granted: 1994-05-11
Abstract: Peptides having the formula (I) and a process for the preparation thereof are disclosed;
 A - X - NH - Y - @ - R (I)
 wherein A represents hydrogen, an amino-protecting group, an acidic amino acid residue or a protected acidic amino acid residue; X represents an amino acid residue or a protected amino acid residue; Y represents a straight chain alkylene group having 2 to 6 carbon atoms or a hydroxy substituted alkylene group having 2 to 6 carbon atoms; R represents a hydroxy-protecting group or a carboxy-protecting group. The compounds and pharmaceutically acceptable salts thereof have neurotropic, cerebral-metabolic and analgesic activity.
Patent DE-3750247-T2 (DE)
Inventor: TICE THOMAS R
IPC: A61K9/14
Filed: 1987-10-21
Granted: 1994-10-27
Abstract: A method and formulation for orally administering a bioactive agent which comprises encapsulating the agent in one or more biodegradable and biocompatible polymer or copolymer excipients to form a microcapsule which is capable of passing through the gastrointestinal tract unaffected and being taken up by the Peyer's patch.
Patent DE-3782844-T2 (DE)
Inventor: LAURA FRONTALI
IPC: C12N15/63
Filed: 1987-03-25
Granted: 1993-06-17
Abstract: Vectors for the cloning and expression of heterologous genes in yeast, said vectors being characteristic in that they contain at least: the entire DNA of the pkD1 plasmid (isolated from Kluyveromyces drosophilarum) or a part of the same, as well as a DNA segment bearing any heterologous gene and the sequence necessary for the expression of said gene. The high stability of yeasts transformed by said vectors allows their utilization on an industrial scale in various biotechnological fields.
Patent DE-3788822-T2 (DE)
Inventor: GOLDSTEIN ALLAN L
IPC: C07K9/00
Filed: 1987-05-15
Granted: 1994-07-28
Abstract: Vaccines effective in the inhibition of infection caused by the family of retroviruses, HTLV-III, Human T-cell Leukemia Virus, LAV, Lymphadenopathy-associated virus, ARV-2, AIDS-Related Virus, (AIDS and AIDS-Related Complex) have been developed from an antisera prepared against thymosin  alpha 1 (T alpha 1), a thymic hormone, as well as from antisera to synthetic peptide fragments of T alpha 1 and antisera to synthetic peptide fragments inclusive of amino acid positions 92-109 of the p17 gag core protein of HTLV-III, LAV and ARV-2. In this 18 amino acid primary sequence there is a 44 to 50% homology between the gag protein and T alpha 1. Immunoglobulin (IgC)-enriched preparations of the T alpha 1 antisera have enhanced activity in blocking viral replication. A diagnostic test capable of directly detecting the presence of HTLV-III, LAV, ARV-2 and related retroviruses associated with AIDS and ARC is also described.
Patent DE-3852706-T2 (DE)
Inventor: MAGOTA KOJI
IPC: C12P21/02
Filed: 1988-03-04
Granted: 1995-05-24
Abstract: A process for the production of a physiologically active peptide (a target peptide) containing cysteine residue, comprising the steps of:     (1) culturing Escherichia coli transformed with a plasmid capable of expressing a fusion protein under control of a promoter of E. coli origin or a promoter of a phage origin, wherein the fusion protein is represented by the following formula:        A - L - B wherein B represents a target peptide containing cysteine residue; A represents a partner polypeptide consisting of 90 to 220 amino acid residue but not containing cysteine residue; and L represents a linker amino acid residue positioned between C-terminal of the partner polypeptide and N-terminal of the target peptide wherein the same amino acid as the linker amino acid is not present in the target peptide, and the linker amino acid is selected so that the peptide bond between the C-terminal of the linker amino acid and the N-terminal of the target peptide is claimed by a protease or the linker amino acid is selectively degraded by a chemical substance; (2) disrupting the cultured cells and obtaining an insoluble fraction containing the fusion protein; (3) solubilizing the fusion protein with a solubilizing agent, and treating the solubilized fusion protein with the protease or the chemical substance to liberate the target peptide, and isolating the target peptide. i
Patent DE-3879062-T2 (DE)
Inventor: HEIDMANN CHARLES
IPC: A47C3/026
Filed: 1988-08-30
Granted: 1993-08-26
Abstract: Ergonomic chair comprising, mounted on a fixed base (10), optionally adjustable in terms of height, a seat/back assembly in a single piece (11), whose flexibility relative to the fixed base results from the combination of the mechanical means (12) and the properties of the material (13) used for its construction. 
<IMAGE>
Patent DE-3885318-T2 (DE)
Inventor: JACOBS MARTIN J
IPC: A23K1/165
Filed: 1988-02-25
Granted: 1994-03-24
Abstract: Estriol is administered to ruminants in dosages from about 0.01-4.0 mg/ruminant/day to promote growth and increase feed utilization efficiency.
Patent DE-3888214-T2 (DE)
Inventor: BRUCE INGRID
IPC: A61F2/30
Filed: 1988-03-30
Granted: 1994-06-30
Abstract: Means for fixing a joint prosthesis the stem of which is provided with a friction surface (2). Said means comprises a substantially homogeneous mixture of a biologically compatible granular material in which the grains (3) have a substantially even particle size distribution and are substantially irregular and/or plastic. A method for fixing said joint prosthesis consists in that a cavity is reamed in the bone in which the prosthesis is to be applied, that grains (3) of biologically compatible material are applied in said cavity so as to form a grain bed, that the prosthesis is driven down into said grain bed until substantially the entire prosthesis stem is surrounded by the grains, that the grains are subjected to an external force, and that a device (5) for retaining the grains is applied on said bed around the prosthesis stem. <IMAGE>
Patent TR-199801732-T2 (TR)
Inventor: BOUCHARD HERV
IPC: C07D413/12
Filed: 1997-03-05
Abstract: Asagidaki genel formüle sahip yeni taksoitler: bunlarin hazirlanmasi ve bunlari içeren ilaç bilesimleri. Z'nin asagidaki (11) genel formülüne sahip: bir kökü temsil ettigi, yukaridaki (1)  genel formülüne sahip yeni ürünler, tümör ve lösemi (kan kanseri) tedavisinde etkili, üstün nitelikli özelliklere sahiptir.
Patent AT-E499960-T2 (AT)
Inventor: BARROW-WILLIAMS TIMOTHY DONALD
Filed: 2007-05-30
Granted: 2011-03-15
Abstract: An injection device (210; 110) is provided that includes a housing (212; 112) adapted to receive a syringe (214; 114) that is movable between a retracted position, in which its needle (218; 118) is contained within the housing, and an extended position, in which its needle (218; 118) extends from the housing (212; 112) through an exit aperture (228; 128). The device (210; 110) includes a drive (230, 231, 232, 234; 130, 131, 132, 134) that acts upon the syringe (214; 114) to advance it from its retracted position to its extended position and to discharge its contents through its needle (218; 118). A syringe carrier (222; 122) is advanced with the syringe (214; 114) and a sleeve (219; 119) restrains the advancement of the syringe carrier (222; 122) as the syringe (214; 114) reaches its extended position. A damping element (225; 125) acts between the syringe carrier (222; 122) and the sleeve (219; 119) to cushion the impact as they come into contact, thereby reducing the transmission of energy from the impact to the components of the drive (230, 231, 232, 234; 130, 131, 132, 134) and preventing their fracture. The damping element (225; 125) also reduces the noise, which may be distressing to a user of the device (210; 110), produced when the syringe carrier (222; 122) and the sleeve (219; 119) come into contact and reduces the pain suffered by a user upon operation of the device (210; 110).
Patent DE-60000938-T2 (DE)
Inventor: MAZURIER FREDERIC
IPC: B22D11/06
Filed: 2000-03-29
Granted: 2003-05-28
Abstract: The invention concerns a method for continuously casting a ferritic stainless steep strip with thickness not more than 10 mm directly from liquid metal between two cooled rolls with horizontal axes and driven in rotation, characterized in that: the liquid metal composition in weight percentages is as follows: % C+% N<=0.12; % Mn<=1; % P<=0.4; % Si<=1; % Mo<=2.5; % Cr between 11 and 19; A1<=1%; % Ti+%Nb+% Zr<=1; the rest being iron and the impurities resulting from preparation; the Upsilp index of the liquid metal ranges between 35% and 60%, Upsilp being defined by the formula: gammap=420% C+470% N+23% Ni+9% Cu+7% Mn 11.5% Cr 11.5% Si 12% Mo 23% V 47% Nb 49% Ti 52% A1+189: the surface roughness of said rolls being more than 5 mum; in the proximity of the meniscus metal liquid present between the rolls an inerting gas is used consisting of at least 60% by volume of a gas soluble in steel.
Patent DE-60002143-T2 (DE)
Inventor: PEREZ GOMARIZ ROSA
IPC: A61K38/22
Filed: 2000-06-02
Granted: 2004-03-18
Abstract: The composition and use of therapeutic agents that inhibit the production of tumoral necrosis factor and interleukin 6 are described. Said agents induce high levels of interleukin 4 for the treatment of endotoxic shock and inflammatory and autoimmune diseases, respectively, in mammals. The composition includes substances such as vasoactive intestinal peptide, adenylate cyclase hypophysary activator peptide and fragments and derivatives thereof.
Patent DE-60003787-T2 (DE)
Inventor: DEBRAS GUY
IPC: B01J19/24
Filed: 2000-01-18
Granted: 2004-06-03
Abstract: A process of producing polyethylene, the process comprising copolymerising ethylene and an alpha-olefinic comonomer comprising from 3 to 8 carbon atoms in the presence of a chromium-based catalyst in a main polymerisation reactor and, in a gas-phase preliminary reactor upstream of the main polymerisation reactor, chemically treating the chromium-based catalyst with at least one treatment agent prior to introduction of the catalyst into the main polymerisation reactor and releasing from the preliminary reactor waste gases produced during the chemical treatment. An apparatus for producing polyethylene, the apparatus comprising a main reactor having an inlet for receiving gaseous olefin monomer and an outlet for outputting polyethylene, and a preliminary reactor connected to a second inlet of the main reactor, the preliminary reactor being arranged to be operable in the gas phase and having at least one respective inlet for receiving a solid catalyst and at least one treatment agent and a respective outlet for releasing waste gases from the preliminary reactor.
Patent DE-60005045-T2 (DE)
Inventor: KLEIN ALOISIO NELMO
IPC: C23C8/36
Filed: 2000-05-23
Granted: 2004-06-03
Abstract: A process for the removal of binder material from powder injected molded parts that employs a low pressure plasma reactor to generate reactive species which react with the binder material in the injected molded part is presented. The reactive species cause the binder material to break down into smaller molecules and thereby be removed from the injected molded part.
Patent DE-60006704-T2 (DE)
Inventor: LUND CARSTEN
IPC: B65D17/40
Filed: 2000-09-14
Granted: 2004-09-30
Abstract: The invention relates to a packaging that is manufactured from a plastics material and comprises a container (50, 150) and a lid (10, 110), said container (50, 150) having an annular and upwardly open receiving channel (60, 160) for a part (34, 134) of the skirt (20, 120), arranged on the outside of the outer wall (54, 154) below a first engaging portion (58, 158), wherein the packaging has a third engaging portion (64, 164, 168') arranged in said receiving channel (60, 160) whereby the packaging obtains a fourth engaging portion (36, 136, 138) arranged on the skirt (20, 120) of the lid (10, 110) below a second engaging portion (28, 128), configured for establishing a snap-locking engagement with said third engaging portion (64, 164, 168') whereby the skirt (20, 120) between the second (28, 128) and the fourth (36, 136, 138) engaging portion comprises a peripheral weakening zone (42, 142) configured to allow, by rupture, separation of the skirt (20, 120) while maintaining said snap-locking engagement between the third (64, 164, 168') and the fourth (36, 136, 138) engaging portions.
Patent DE-60007462-T2 (DE)
Inventor: ROINTRU CLAUDE
IPC: F16H7/08
Filed: 2000-01-21
Granted: 2004-12-02
Abstract: The belt tensioner has one end (3) for fixing to a support and a second end (13) with a tensioning wheel holder (17), the two ends being connected by a spring (27) surrounding a guide. The guide has a tube (31) which acts as a cylinder for a hydraulic piston (33) forming at least one variable volume chamber (85), with an annular chamber (67) inside an elastomer sleeve (69) surrounding the tube. The tube also contains a fluid flow regulator.